Aristoloche, Aristoloche Clématite, Aristoloche de Texas, Aristoloche des Vignes, Aristoloche de Virginie, Aristoloche Vulgaire, Aristolochia auricularia, Aristolochia clematitis, Aristolochia fangchi, Aristolochia heterophylla, Aristolochia kwangsiensis, Aristolochia manshuriensis, Aristolochia moupinensis, Aristolochia reticulata, Aristolochia serpentaria, Aristoloquia, Birthwort, Guan Mu Tong, Guang Fang Ji, Long Birthwort, Pelican Flower, Poison de Terre, Pomerasse, Ratelaine, Rateline, Red River Snakeroot, Sangree Root, Sangrel, Sarrasine, Serpentaire, Serpentaire de la Rivière Rouge, Serpentaria, Snakeroot, Snakeweed, Texas Snakeroot, Virginia Serpentary, Virginia Snakeroot.
Aristolochia is a plant. The parts that grow above the ground and the root are used to make medicine.
Despite serious safety concerns, aristolochia is used to prevent seizures, increase sexual desire, boost the immune system, and start menstruation. It is also used to treat snakebite, intestinal pain, gallbladder pain, arthritis, gout, achy joints (rheumatism), eczema, weight loss, and wounds.
How does it work?
There isn't enough information to know how aristolochia works.
SLIDESHOW
Vitamin D Deficiency: How Much Vitamin D Is Enough? See SlideshowInsufficient Evidence to Rate Effectiveness for...
- Sexual arousal.
- Convulsions (seizures).
- Boosting the body's defense system (immune system).
- Starting menstruation.
- Colic.
- Gallbladder pain.
- Arthritis.
- Gout.
- Achy joints (rheumatism).
- A skin condition called eczema.
- Weight loss.
- Wounds.
- Other conditions.
Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, and Insufficient Evidence to Rate (detailed description of each of the ratings).
Aristolochia is UNSAFE. It contains aristolochic acid, which is toxic to the kidneys and causes cancer. Use of aristolochia can cause kidney damage leading to the need for kidney dialysis and kidney transplant. It also greatly increases the risk of bladder cancer and other urinary tract cancers.
Health authorities around the world have taken action to protect the public against aristolochia and aristolochic acid. Aristolochia is banned in Germany, Austria, France, Great Britain, Belgium, and Japan. In the U.S., the Food and Drug Administration (FDA) seizes any product that it believes might contain aristolochic acid. The FDA will not release the product until its maker proves the product does not contain aristolochic acid. Health Canada, the Canadian health authority, removed five aristolochia-containing Chinese herbal medicine products from sale. The products include Touku Natural Herbal Rheumatic Pills, two brands of Tri-Snakegall & Fritillary Powder, Tracheitis Pills, and Gastropathy Capsules.
QUESTION
Next to red peppers, you can get the most vitamin C from ________________. See AnswerKidney disease: Aristolochia might bring on early kidney failure in people with kidney disease.
The appropriate dose of aristolochia depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for aristolochia. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Abe, F., Nagafuji, S., Yamauchi, T., Okabe, H., Maki, J., Higo, H., Akahane, H., Aguilar, A., Jimenez-Estrada, M., and Reyes-Chilpa, R. Trypanocidal constituents in plants 1. Evaluation of some Mexican plants for their trypanocidal activity and active constituents in Guaco, roots of Aristolochia taliscana. Biol Pharm Bull 2002;25(9):1188-1191. View abstract.
Abubakar MS, Balogun EE, Abdurahman EM, Nok AJ, Shok M, Mohammed A, and Garba M. Ethnomedical Treatment of Poisonous Snakebites: Plant Extract Neutralized Naja nigricollis Venom. Pharmaceutical Biology 2006;44(5):343-348.
Aristolochia and renal failure. WHO Drug Information 1999;13(3):174.
Arlt, V. M., Pfohl-Leszkowicz, A., Cosyns, J., and Schmeiser, H. H. Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. Mutat.Res 7-25-2001;494(1-2):143-150. View abstract.
Arlt, V. M., Stiborova, M., and Schmeiser, H. H. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002;17(4):265-277.
Ashraf, H. Chinese herbal remedy linked to kidney failure. Lancet 8-7-1999;354(9177):494.
Balachandran, P., Wei, F., Lin, R. C., Khan, I. A., and Pasco, D. S. Structure activity relationships of aristolochic acid analogues: toxicity in cultured renal epithelial cells. Kidney Int 2005;67(5):1797-1805. View abstract.
Beaulieu, J. E. Herbal therapy interactions with immunosuppressive agents. US Pharmacist (USA) 2001;26:HS-13-HS-14.
Broussalis, A. M., Ferraro, G. E., Martino, V. S., Pinzon, R., Coussio, J. D., and Alvarez, J. C. Argentine plants as potential source of insecticidal compounds. J Ethnopharmacol 11-1-1999;67(2):219-223. View abstract.
Camporese, A., Balick, M. J., Arvigo, R., Esposito, R. G., Morsellino, N., De Simone, F., and Tubaro, A. Screening of anti-bacterial activity of medicinal plants from Belize (Central America). J Ethnopharmacol. 2003;87(1):103-107. View abstract.
Capasso, A., Piacente, S., De Tommasi, N., Rastrelli, L., and Pizza, C. The effect of isoquinoline alkaloids on opiate withdrawal. Curr Med Chem 2006;13(7):807-812. View abstract.
Centre for Reviews and Dissemination (CRD). Systematic review: hepatotoxic events associated with herbal medicinal products. 2004;
Chan, T. Y., Tam, H. P., Lai, C. K., and Chan, A. Y. A multidisciplinary approach to the toxicologic problems associated with the use of herbal medicines. Ther Drug Monit. 2005;27(1):53-57. View abstract.
Che, C. T., Ahmed, M. S., Kang, S. S., Waller, D. P., Bingel, A. S., Martin, A., Rajamahendran, P., Bunyapraphatsara, N., Lankin, D. C., Cordell, G. A., and . Studies on Aristolochia III. Isolation and biological evaluation of constituents of Aristolochia indica roots for fertility-regulating activity. J Nat.Prod. 1984;47(2):331-341. View abstract.
Chen, John K. Nephropathy Associated with the Use of Aristolochia Westlandi (guan fang ji) and Aristolochia Manshuriensis (guan mu tong). California Journal of Oriental Medicine (CJOM) 2000;11(1):46-47.
Chen, Y. G., Yu, L. L., Huang, R., Liu, J. C., Lv, Y. P., and Zhao, Y. 3"-hydroxyamentoflavone and its 7-O-methyl ether, two new biflavonoids from Aristolochia contorta. Arch Pharm Res 2005;28(11):1233-1235. View abstract.
Chou, L. D., Chen, Z. M., Liang, Y. L., Che, D., and Chen, S. L. Study on determination of aristolochic acid in Radix stephaniae Tetradrae (Aristolochia fangchi). Bull.Chin.Mater.Med. 1986;11:363-365.
Choudhury, M. K. and Haruna, A. K. Phytochemical investigation of Aristolochia albida Duch. Indian Journal of Pharmaceutical Sciences 1994;56:230-231.
Choudhury, M. K., Haruna, A. K., Johnson, E. C., and Houghton, P. Structural elucidation of columbin, a diterpene isolated from the rhizomes of Aristolochia albida. Indian Journal of Pharmaceutical Sciences 1997;59:34-37.
Cisowski, W., Rzadkowska-Bodalska, H., and Szymczak, J. Fatty acids of lipids from the herb and roots of Aristolochia species cultivated in Poland. Herba Polonica 1977;23:117-120.
Cortes, D., Dadoun, H., Paiva, R. L., and De Oliveira, A. B. New bisbenzylisoquinoline alkaloids isolated from the leaves of Aristolochia gigantea. Journal of Natural Products 1987;50:910-914.
Cosyns, J. P. Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date. Drug Saf 2003;26(1):33-48. View abstract.
Damu, AG, Kuo, PC, Leu, YL, Chan, YY, and Wu, TS. Chemical constituents and pharmacology of the Formosan Aristolochia species. Chinese Pharmaceutical Journal (Taiwan) 2003;55:1-33.
de Barros, Machado T., Leal, I. C., Kuster, R. M., Amaral, A. C., Kokis, V., de Silva, M. G., and dos Santos, K. R. Brazilian phytopharmaceuticals--evaluation against hospital bacteria. Phytother Res 2005;19(6):519-525. View abstract.
Debelle, F. D., Nortier, J. L., De Prez, E. G., and Chang, Johnny. New Study Examines 'Chinese-herb Nephropathy'. California Journal of Oriental Medicine (CJOM) 2002;13(2):10.
El Tahir, K. E. Pharmacological actions of magnoflorine and aristolochic acid-1 isolated from the seeds of Aristolochia bracteata. International Journal of Pharmacognosy 1991;29:101-110.
El-Sebakhy, N., Richomme, P., Taaima, S., and Shamma, M. (-)-Temuconine, a new bisbenzylisoquinoline alkaloid from Aristolochia elegans. Journal of Natural Products 1989;52:1374-1375.
Enriquez, R. G., Chavez, M. A., and Reynolds, W. F. Phytochemical investigations of plants of the genus Aristolochia, 1. Isolation and NMR spectral characterization of eupomatenoid derivatives. J Nat.Prod. 1984;47(5):896-899. View abstract.
Gadhi, C. A., Benharref, A., Jana, M., and Lozniewski, A. Anti-Helicobacter pylori activity of Aristolochia paucinervis Pomel extracts. J Ethnopharmacol. 2001;75(2-3):203-205. View abstract.
Gadhi, C. A., Benharref, A., Jana, M., Basile, A. M., Contet-Audonneau, N., and Fortier, B. Antidermatophytic properties of extracts from the leaves of Aristolochia paucinervis Pomel. Phytother.Res. 2001;15(1):79-81. View abstract.
Gadhi, C. A., Hatier, R., Mory, F., Marchal, L., Weber, M., Benharref, A., Jana, M., and Lozniewski, A. Bactericidal properties of the chloroform fraction from rhizomes of Aristolochia paucinervis Pomel. J Ethnopharmacol. 2001;75(2-3):207-212. View abstract.
Gadhi, C. A., Weber, M., Mory, F., Benharref, A., Lion, C., Jana, M., and Lozniewski, A. Antibacterial activity of Aristolochia paucinervis Pomel. J.Ethnopharmacol. 1999;67(1):87-92. View abstract.
Georgopoulou, C., Aligiannis, N., Fokialakis, N., and Mitaku, S. Acretoside, a new sucrose ester from Aristolochia cretica. J Asian Nat Prod Res 2005;7(6):799-803. View abstract.
Grollman, A. P., Shibutani, S., Moriya, M., Miller, F., Wu, L., Moll, U., Suzuki, N., Fernandes, A., Rosenquist, T., Medverec, Z., Jakovina, K., Brdar, B., Slade, N., Turesky, R. J., Goodenough, A. K., Rieger, R., Vukelic, M., and Jelakovic, B. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl.Acad Sci U.S.A 7-17-2007;104(29):12129-12134. View abstract.
Haruna, A. K. and Choudhury, M. K. In vivo antisnake venom activity of a furanoid diterpene from Aristolochia albida Duch (Aristolochiaceae). Indian Journal of Pharmaceutical Sciences 1995;57:222-224.
Hashimoto, K., Higuchi, M., Makino, B., Sakakibara, I., Kubo, M., Komatsu, Y., Maruno, M., and Okada, M. Quantitative analysis of aristolochic acids, toxic compounds, contained in some medicinal plants. J Ethnopharmacol 1999;64(2):185-189. View abstract.
Hayashi, N., Sugiyama, Y., Komae, H., and Sakao, T. Studies on the chemical constituents of the food plants of the insects. Part 1. Terpenic constituents of Aristolochia debilis, Heterotropa spp., and Crataeva religiosa. Journal of Natural Products 1987;50:769-770.
Hinou, J., Demetzos, C., Harvala, C., and Roussakis, C. Cytotoxic and antimicrobial principles from the roots of Aristolochia longa. Int.J.Crude Drug Res 1990;28:149-151.
Hranjec, T., Kovac, A., Kos, J., Mao, W., Chen, J. J., Grollman, A. P., and Jelakovic, B. Endemic nephropathy: the case for chronic poisoning by aristolochia. Croat.Med J 2005;46(1):116-125. View abstract.
Hussein, F. T. A phytochemical investigation of the seeds of Aristolochia bracteata. Planta Med 1970;18(1):30-35. View abstract.
Ionescu, F., Jolad, S. D., and Cole, J. R. Dehydrodiisoeugenol: a naturally occurring lignan from Aristolochia taliscana (Aristolochiaceae). J Pharm.Sci 1977;66(10):1489-1490. View abstract.
Ioset, J. R., Raoelison, G. E., and Hostettmann, K. Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens. Food Chem Toxicol 2003;41(1):29-36. View abstract.
Kery, A., Askari, A. A., and Sharefi, K. A. Int.J.Crude Drug Res. 1983;
Kessler, D. A. Cancer and herbs. N Engl.J Med 6-8-2000;342(23):1742-1743. View abstract.
Koh, H. L., Wang, H., Zhou, S., Chan, E., and Woo, S. O. Detection of aristolochic acid I, tetrandrine and fangchinoline in medicinal plants by high performance liquid chromatography and liquid chromatography/mass spectrometry. J Pharm Biomed.Anal. 2-24-2006;40(3):653-661. View abstract.
Laing, C., Hamour, S., Sheaff, M., Miller, R., and Woolfson, R. Chinese herbal uropathy and nephropathy. Lancet 7-22-2006;368(9532):338. View abstract.
Lebeau, C., Arlt, V. M., Schmeiser, H. H., Boom, A., Verroust, P. J., Devuyst, O., and Beauwens, R. Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells. Kidney Int 2001;60(4):1332-1342. View abstract.
Lee, H. S. and Han, D. S. A new acylated N-glycosyl lactam from Aristolochia contorta. J Nat.Prod. 1992;55(9):1165-1169. View abstract.
Leitao, G. G. and Kaplan, M. A. Chemistry of the genus Aristolochia. Revista Brasileria de Farmacia 1992;73:65-75.
Lemos, V. S., Thomas, G., and Barbosa Filho, J. M. Pharmacological studies on Aristolochia papillaris Mast. (Aristolochiaceae). J Ethnopharmacol. 1993;40(2):141-145. View abstract.
Liao, Jung-Chun, Lin, Kun-Hung, Ho, Hui-Ya, Peng, Wen-Huang, Yao, Xinsheng, Kitanaka, Susumu, and Wu, Jin-Bin. Inhibitory Effects of 87 Species of Traditional Chinese Herbs on Nitric Oxide Production in RAW264.7 Macrophages, Activated with Lipopolysaccharide and Interferon-ã. Pharmaceutical Biology 2005;43(2):158-163.
Liebman, B. Herbs and cancer. Nutrition Action Health Letter 2000;27(7):11-13.
Lo, S. H., Wong, K. S., Arlt, V. M., Phillips, D. H., Lai, C. K., Poon, W. T., Chan, C. K., Mo, K. L., Chan, K. W., and Chan, A. Detection of Herba Aristolochia Mollissemae in a patient with unexplained nephropathy. Am.J Kidney Dis. 2005;45(2):407-410. View abstract.
Lou, F. C., Ding, L. S., Li, L. L., and Wu, M. Y. Studies on chemical constituents of Bei Madouling (Aristolochia contorta). Part 1. Chinese Traditional and Herbal Drugs 1986;17:390-391.
Meinl, W., Pabel, U., Osterloh-Quiroz, M., Hengstler, J. G., and Glatt, H. Human sulphotransferases are involved in the activation of aristolochic acids and are expressed in renal target tissue. Int J Cancer 3-1-2006;118(5):1090-1097. View abstract.
Mongelli, E., Martino, V., Coussio, J., and Ciccia, G. Screening of Argentine medicinal plants using the brine shrimp microwell cytotoxicity assay. International Journal of Pharmacognosy 1996;34:249-254.
Mongelli, E., Pampuro, S., Coussio, J., Salomon, H., and Ciccia, G. Cytotoxic and DNA interaction activities of extracts from medicinal plants used in Argentina. J Ethnopharmacol 2000;71(1-2):145-151. View abstract.
Murillo-Alvarez, JI, Encarnacion, DR, and Franzblau, SG. Antimicrobial and cytotoxic activity of some medicinal plants from Baja California Sur (Mexico). Pharmaceutical Biology (Netherlands) 2001;39:445-449.
News Potpourri. Southern Medical Journal 2000;93(11):1129-1130.
Nok, A. J., Sallau, B. A., Onyike, E., and Useh, N. M. Columbin inhibits cholesterol uptake in bloodstream forms of Trypanosoma brucei-A possible trypanocidal mechanism. J Enzyme Inhib.Med Chem 2005;20(4):365-368. View abstract.
Nortier, J. [Renal interstitial fibrosis and urotelial carcinomas after ingestion of a Chinese herb (Aristolochia fangchi)]. Nephrologie 2002;23(1):37-38. View abstract.
Otero, R., Nunez, V., Barona, J., Fonnegra, R., Jimenez, S. L., Osorio, R. G., Saldarriaga, M., and Diaz, A. Snakebites and ethnobotany in the northwest region of Colombia. Part III: neutralization of the haemorrhagic effect of Bothrops atrox venom. J.Ethnopharmacol. 2000;73(1-2):233-241. View abstract.
Oyedeji, O. A., Adeniyi, B. A., Ajayi, O., and Konig, W. A. Essential oil composition of Piper guineense and its antimicrobial activity. Another chemotype from Nigeria. Phytother Res 2005;19(4):362-364. View abstract.
Peng, G. P., Lou, F. C., and Chen, Y. Z. Studies on the chemical constituents of Tubeflower Dutchmanspipe (Aristolochia tubflora). Chinese Traditional and Herbal Drugs 1996;26:623-626.
Pistelli, L., Nieri, E., Bilia, A. R., Marsili, A., and Scarpato, R. Chemical constituents of Aristolochia rigida and mutagenic activity of aristolochic acid IV. J Nat.Prod. 1993;56(9):1605-1608. View abstract.
Podolesov, B. and Zdravkovski, Z. Isolation and identification of the basic components of Aristolochia macedonica. Acta Pharm.Jugosl. 1980;30:161-162.
Rastrelli, L., Capasso, A., Pizza, C., De Tommasi, N., and Sorrentino, L. New protopine and benzyltetrahydroprotoberberine alkaloids from Aristolochia constricta and their activity on isolated guinea-pig ileum. J Nat.Prod. 1997;60(11):1065-1069. View abstract.
Rucker, G. [9-hydroxy-delta-1(10)-aristolenon-(2) (debilon) from Nardostachys chiniensis]. Planta Med 1970;19(1):16-18. View abstract.
Rucker, V. G. and Chung, B. S. [Aristolochic acids from Aristolochia manshuriensis (author's transl)]. Planta Med 1975;27(1):68-71. View abstract.
Ruffa, M. J., Ferraro, G., Wagner, M. L., Calcagno, M. L., Campos, R. H., and Cavallaro, L. Cytotoxic effect of Argentine medicinal plant extracts on human hepatocellular carcinoma cell line. J Ethnopharmacol. 2002;79(3):335-339. View abstract.
Schaneberg, B. T. and Khan, I. A. Analysis of products suspected of containing Aristolochia or Asarum species. J.Ethnopharmacol. 2004;94(2-3):245-249. View abstract.
Schaneberg, B. T., Applequist, W. L., and Khan, I. A. Determination of aristolochic acid I and II in North American species of Asarum and Aristolochia. Pharmazie 2002;57(10):686-689. View abstract.
Schutte, H. R., Orban, U., and Mothes, K. Biosynthesis of aristolochic acid. Eur J Biochem 1967;1(1):70-72. View abstract.
Sosa, S., Balick, M. J., Arvigo, R., Esposito, R. G., Pizza, C., Altinier, G., and Tubaro, A. Screening of the topical anti-inflammatory activity of some Central American plants. J Ethnopharmacol 2002;81(2):211-215. View abstract.
Sun, L., An, R., and Zhuang, W. [Renal toxicity of Aristolochia and its prevention]. Zhong.Yao Cai. 2002;25(5):369-371. View abstract.
Tan, H. G. and Liu, Y. Q. [Chemical components of Aristolochia contorta Bge]. Zhongguo Zhong.Yao Za Zhi. 1994;19(11):677-8, 703. View abstract.
Urzua, A., Freyer, A. J., and Shamma, M. Aristolodione, a 4,5-dioxoaporphine from Aristolochia chilensis. Journal of Natural Products 1987;50:305-306.
Urzua, A., Salgado, G., Cassels, B. K., and Eckhardt, G. Aristolochic Acids in Aristolochia chilensis. Planta Med 1982;45(5):51-52. View abstract.
Van Ypersele, De Strihou and Jadoul, M. Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. Nephrol.Dial.Transplant. 2002;17(10):1852. View abstract.
Velazquez, E., Tournier, H. A., Mordujovich, de Buschiazzo, Saavedra, G., and Schinella, G. R. Antioxidant activity of Paraguayan plant extracts. Fitoterapia 2003;74(1-2):91-97. View abstract.
Violon, C. Belgian (Chinese herb) nephropathy: why? J Pharm Belg. 1997;52(1):7-27. View abstract.
Wen, Y. J., Su, T., Tang, J. W., Zhang, C. Y., Wang, X., Cai, S. Q., and Li, X. M. Cytotoxicity of phenanthrenes extracted from Aristolochia contorta in human proximal tubular epithelial cell line. Nephron Exp Nephrol 2006;103(3):e95-e102. View abstract.
Wu, P. L., Su, G. C., and Wu, T. S. Constituents from the stems of Aristolochia manshuriensis. J Nat.Prod. 2003;66(7):996-998. View abstract.
Wu, T. S., Chan, Y. Y., and Leu, Y. L. Constituents of the roots and stems of Aristolochia mollissima. J Nat.Prod. 2001;64(1):71-74. View abstract.
Wu, T. S., Chan, Y. Y., and Leu, Y. L. The constituents of the root and stem of Aristolochia cucurbitifolia Hayata and their biological activity. Chem.Pharm.Bull.(Tokyo) 2000;48(7):1006-1009. View abstract.
Wu, T. S., Leu, Y. L., and Chan, Y. Y. Constituents from the stem and root of Aristolochia kaempferi. Biol.Pharm.Bull. 2000;23(10):1216-1219. View abstract.
Wu, T. S., Tsai, Y. L., Damu, A. G., Kuo, P. C., and Wu, P. L. Constituents from the root and stem of Aristolochia elegans. J Nat.Prod. 2002;65(11):1522-1525. View abstract.
Yu, L. L., Huang, R., Lv, Y. P., Zhao, Y., and Chen, Y. A new biflavonoid from Aristolochia contorta. Pharmazie 2005;60(10):789-791. View abstract.
Zhai, H., Nakatsukasa, M., Mitsumoto, Y., and Fukuyama, Y. Neurotrophic effects of talaumidin, a neolignan from Aristolochia arcuata, in primary cultured rat cortical neurons. Planta Med 2004;70(7):598-602. View abstract.
Zhang, C. Y., Wang, X., Su, T., Ma, C. M., Wen, Y. J., Shang, M. Y., Li, X. M., Liu, G. X., and Cai, S. Q. New aristolochic acid, aristololactam and renal cytotoxic constituents from the stem and leaves of Aristolochia contorta. Pharmazie 2005;60(10):785-788. View abstract.
Zhou, F. X., Liang, P. Y., Qu, C. J., and Wen, J. [Studies on the chemical constituents of Aristolochia kwangsiensis Chun et How ex C F Liang]. Yao Xue.Xue.Bao. 1981;16(8):638-640. View abstract.
Zhu, M. and Phillipson, J. D. Hong Kong samples of the traditional Chinese medicine Fang Ji contain aristolochic acid toxins. International Journal of Pharmacognosy 1996;34:283-289.
Zhu, SM, Liu, MQ, Liu, JB, Chen, L, Zhu, LG, and et al. Protective effects of ginkgo biloba leaf on acute renal injury caused by Aristolochia manshuriensis Kom. Herald of Medicine 2003;22:760-763.
Zhu, Y. P. Toxicity of the Chinese herb mu tong (Aristolochia manshuriensis). What history tells us. Adverse Drug React.Toxicol.Rev. 2002;21(4):171-177. View abstract.
Arandjelovic C. Canadian health officials pull Chinese herbal drugs. (Reprinted from Reuters). Richters HerbLetter November 23, 1999.
Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002;17:265-77. View abstract.
Chang CH, Wang YM, Yang AH, Chiang SS. Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. Am J Nephrol 2001;21:441-8. View abstract.
Cronin AJ, Maidment G, Cook T, et al Aristolochic acid as a causative factor in a case of Chinese herbal nephropathy. Nephrol Dial Transplant 2002;17:524-5. View abstract.
Hong CH, Hur SK, Oh OJ, et al. Evaluation of natural products on inhibition of inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) in cultured mouse macrophage cells. J Ethnopharmacol 2002;83:153-9. View abstract.
Lewis CJ, Alpert S. Letter to health care professionals -- FDA concerned about botanical products, including dietary supplements, containing aristolochic acid. Office of Nutritional Products, Labeling, Dietary Supplements. Center for Food Safety and Applied Nutrition. May 31, 2000.
Lord GM, Cook T, Arlt VM, et al. Urothelial malignant disease and Chinese herbal nephropathy. Lancet 2001;358:1515-6. View abstract.
Lord GM, Tagore R, Cook T, et al. Nephropathy caused by Chinese herbs in the UK. Lancet 1999;354:481-2. View abstract.
Martinez M. C., Nortier J., Vereerstraeten P., Vanherweghem J. L. Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. Nephrol.Dial.Transplant. 2002;17(3):408-12. View abstract.
Nortier JL, Martinez MC, Schmeiser HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000;342:1686-92. View abstract.
Nortier JL, Vanherweghem JL. Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). Toxicology 2002;181-182:577-80. View abstract.
van Ypersele de Strihou C, Vanherweghem JL. The tragic paradigm of Chinese herbs nephropathy. Nephrol Dial Transplant 1995;10:157-60.
Yu Y., Zheng F. L., Li H. [Chinese herbs-induced renal failure with Fanconi syndrome: a report of 6 cases]. Zhonghua Nei Ke.Za Zhi. 2003;42:110-12. View abstract.
Zhou S, Koh HL, Gao Y, et al. Herbal bioactivation: the good, the bad and the ugly. Life Sci 2004;74:935-68. View abstract.